Highlights of latest advances in antithrombotics.
Mousa
Shaker A
SA
Albany College of Pharmacy, NY, USA.
D000244:Adenosine Diphosphate / Q000037:antagonists & inhibitors; D000818:Animals; D001792:Blood Platelets / Q000187:drug effects; D000077144:Clopidogrel; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D013923:Thromboembolism / Q000188:drug therapy; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D000244:Adenosine Diphosphate; D000077144:Clopidogrel; D013988:Ticlopidine